Philip Sin - Biotech Executive & Investor

Phillip Sin is a serial biotech executive and investor, currently Head of Capital Markets and Corporate Development at Belief BioMed Group, a clinical-stage biotechnology company based in Shanghai, focused on gene therapy. He was the former CFO of HifibioTherapeutics, a clinical-stage biotech company specialising in immunotherapy.

Prior to his biotech executive journey, he was a seasoned investment banker with 20+ years’ experience with several firms. He is also a venture investor in iRenix Medical, a company engaged in ophthalmic devices and drug development.

Philip is a Magna cum Laude graduate of Dartmouth College.